Furthermore, our textile-stacking method, inspired by conventional fabrication methods from the apparel industry, along with the lightweight fabrics used, allows the device to be worn more comfortably than other SCT devices. Our open-source, low-profile, and lightweight (140 g) device costs $62, less than one-third the cost the least expensive alternative and one-half the weight of lightest alternative approved by the US Food and Drug Administration (FDA), presenting the opportunity to more effectively provide SCT to socioeconomically disadvantaged individuals. Expanding on concepts from the field of soft robotics, textile sheets are thermally bonded to form pneumatic actuators, which are controlled by an inconspicuous and tetherless electronic onboard supply of pressurized air. Here, we present a low-cost wearable device to administer SCT, constructed using a stacked lamination fabrication approach. Meanwhile, sequential compression therapy (SCT) offers a low-risk alternative, but is currently expensive and unwieldy, and often requires the patient to be immobilized during administration.
Treatment with long-term administration of medication can adversely affect other organs, and surgeries such as coronary artery grafts are risky. In 2020, cardiovascular diseases resulted in 25% of unnatural deaths in the United States. Department of Mechanical Engineering, Rice University, Houston, TX, United States.
Mark Schara †, Mingde Zeng †, Barclay Jumet* ‡ and Daniel J.
0 kommentar(er)
